What are Viridian Therapeutics, Inc.'s profit margins?

Viridian Therapeutics, Inc. (VRDN) runs a 36.3% gross margin and a -543.9% operating margin, with a -508.5% net margin.

Where do Viridian Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Viridian Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Viridian Therapeutics, Inc. VRDN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-543.9%+111,047pp	-512.9%+98,506pp	-463.5%+93,259pp	-121,831.1%-34,753pp	-111,591.1%-28,996pp
Net margin	-508.5%+101,584pp	-483.6%+88,904pp	-426.6%+84,701pp	-112,806.9%-33,621pp	-102,092.4%-26,355pp
Returns
Return on equity	-58.1%-6.2pp	-49.2%-0.7pp	-49.9%+2.0pp	-65.9%-11.9pp	-51.9%-5.2pp
Return on invested capital	-76.5%-10.7pp	-64.8%-0.9pp	-73.9%+4.2pp	-85.9%-12.1pp	-65.8%-4.9pp
Efficiency
Asset turnover	0.1×+0.1×	0.1×+0.1×	0.1×+0.1×	0×0.0×	0×0.0×
Liquidity
Current ratio	15.1×-4.3×	12.6×-2.8×	11.3×-7.3×	11×-4.8×	19.5×-4.5×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$2B+82.0%	$2.97B+95.6%	$1.76B+1.4%	$1.2B+44.1%	$1.1B-0.1%
Price / sales	28.2×-3,609×	41.9×-4,986×	24.9×-5,727×	3,921.8×+1,039×	3,637.1×-179×
Price / book	3.1×+1.3×	4.1×+1.9×	3.5×+1.0×	2.3×+0.8×	1.8×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Viridian Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Viridian Therapeutics, Inc.'s profit margins?: Viridian Therapeutics, Inc. (VRDN) runs a 36.3% gross margin and a -543.9% operating margin, with a -508.5% net margin.
Where do Viridian Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Viridian Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.